Bromocriptine Mesylate Capsule
Product Images NDC 65841-654

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 65841-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D7dc088b D348 4fdc 9a6c A6a1d435148f 02

Bromocriptine Mesylate Capsules, USP is a medication provided in a pack of 100 capsules. Each capsule contains 5 mg of Bromocriptine mesylate, USP and it is manufactured by Cadila Healthcare Ltd in Ahmedabas, India. The package insert provides comprehensive information on the usual dosage and complete prescribing information. It is required to store this medication at 20°C to 25°C (68°F to 77°F) to maintain its quality. The container should also be kept in a light-resistant area, and it is recommended to dispense in a tightly closed container. The medication should be kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.